[Secondary hyperparathyroidism and anemia. Effects of a calcimimetic on the control of anemia in chronic hemodialysed patients. Pilot Study].

Unlabelled: The main cause of resistance to erythropoiesis-stimulating agents (ESA) used for treatment of anemia in chronic hemodialysed patients (CHP) is the iron deficiency, absolute or functional. Secondary hyperparathyroidism (SHPT) is a secondary factor of resistance. Indeed, it has been reported in the literature an improvement of anemia parameters after surgical parathyroidectomy (PTX).

[Reference values and prevalence of lipidic profile alterations in adolescents].

Introduction: Altered lipid metabolism along with other cardiovascular risk factors promotes atherosclerosis at early age, leading to cardiovascular disease development. We aimed to estimate the prevalence of abnormal lipid profle in school adolescents from the city of Posadas, Misiones, Argentina, and describe the distribution of values in an apparently healthy subgroup.

Population And Methods: Descriptive cross-sectional study in a sample of students from 12 to 18 years of age.